These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37872658)

  • 1. Evidence-based Management of Major Bleeding in Patients Receiving Direct Oral Anticoagulants: An Updated Narrative Review on the Role of Specific Reversal Agents.
    Al Aseri Z; AlGahtani FH; Bakheet MF; Al-Jedai AH; Almubrik S
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231202655. PubMed ID: 37872658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversal agents for severe bleeding associated with direct oral anticoagulants].
    Giubilato S; Lucà F; Di Fusco SA; Amico F; Colivicchi F; Gulizia MM
    G Ital Cardiol (Rome); 2022 Oct; 23(10):734-745. PubMed ID: 36169124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct (New) Oral Anticoagulants (DOACs): Drawbacks, Bleeding and Reversal.
    Karcioglu O; Zengin S; Ozkaya B; Ersan E; Yilmaz S; Afacan G; Abuska D; Hosseinzadeh M; Yeniocak S
    Cardiovasc Hematol Agents Med Chem; 2022; 20(2):103-113. PubMed ID: 34521332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding.
    Grottke O; Afshari A; Ahmed A; Arnaoutoglou E; Bolliger D; Fenger-Eriksen C; von Heymann C
    Eur J Anaesthesiol; 2024 May; 41(5):327-350. PubMed ID: 38567679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.
    Gómez-Outes A; Alcubilla P; Calvo-Rojas G; Terleira-Fernández AI; Suárez-Gea ML; Lecumberri R; Vargas-Castrillón E
    J Am Coll Cardiol; 2021 Jun; 77(24):2987-3001. PubMed ID: 34140101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants (DOAC) - Management of emergency situations.
    Lindhoff-Last E
    Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.
    Kaide CG; Gulseth MP
    J Emerg Med; 2020 Feb; 58(2):217-233. PubMed ID: 31831187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding.
    Ojetti V; Saviano A; Brigida M; Saviano L; Migneco A; Franceschi F
    Rev Recent Clin Trials; 2020; 15(4):309-320. PubMed ID: 32579506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols.
    Huisman MV; Fanikos J
    Am J Emerg Med; 2016 Nov; 34(11S):46-51. PubMed ID: 27697438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines.
    Milling TJ; Refaai MA; Sengupta N
    Dig Dis Sci; 2021 Nov; 66(11):3698-3714. PubMed ID: 33403486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants in trauma patients.
    Schöchl H; Grottke O; Schmitt FCF
    Curr Opin Anaesthesiol; 2024 Apr; 37(2):93-100. PubMed ID: 38390987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols.
    Huisman MV; Fanikos J
    Am J Med; 2016 Nov; 129(11S):S89-S96. PubMed ID: 27569673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal strategies in patients treated with direct oral anticoagulants.
    Gressenberger P
    Vasa; 2019 Aug; 48(5):389-392. PubMed ID: 30719950
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What we have learned about direct oral anticoagulant reversal.
    Siegal DM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):198-203. PubMed ID: 31808835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How can we reverse bleeding in patients on direct oral anticoagulants?
    Crowther M; Cuker A
    Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants and their antagonists in perioperative practice.
    Levy JH; Mamoun N
    Curr Opin Anaesthesiol; 2023 Aug; 36(4):394-398. PubMed ID: 37314165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulants: a review on the current role and scope of reversal agents.
    Chaudhary R; Sharma T; Garg J; Sukhi A; Bliden K; Tantry U; Turagam M; Lakkireddy D; Gurbel P
    J Thromb Thrombolysis; 2020 Feb; 49(2):271-286. PubMed ID: 31512202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants.
    Sarode R; Welsby IJ; Hoffman M
    Ann Emerg Med; 2023 Sep; 82(3):341-361. PubMed ID: 37204347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.